BioCryst Pharmaceuticals BCRX Taxes withheld on stock-based awards included in accrued expenses
Taxes withheld on stock-based awards included in accrued expenses at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept bcrx:WithholdingTaxesAccrued.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's taxes withheld on stock-based awards included in accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's taxes withheld on stock-based awards included in accrued expenses?
- BioCryst Pharmaceuticals (BCRX) reported taxes withheld on stock-based awards included in accrued expenses of $3.17M in Q1 2026.
- How has BioCryst Pharmaceuticals's taxes withheld on stock-based awards included in accrued expenses changed year-over-year?
- BioCryst Pharmaceuticals's taxes withheld on stock-based awards included in accrued expenses increased by 1049.3% year-over-year, from $276K to $3.17M.
- What is the long-term trend for BioCryst Pharmaceuticals's taxes withheld on stock-based awards included in accrued expenses?
- Over 2 years (2021 to 2023), BioCryst Pharmaceuticals's taxes withheld on stock-based awards included in accrued expenses has grown at a 108.6% compound annual growth rate (CAGR), from $984K to $4.28M.
- What does taxes withheld on stock-based awards included in accrued expenses mean?
- Represents the amount of tax obligations withheld from employees on behalf of tax authorities related to stock-based compensation awards. This metric tracks the cash flow impact of tax liabilities arising from equity-based incentive programs.